Since its introduction in 1970, the Du Pont Automatic Clinical Analyzer ("aca") has measured uric acid by measuring the reduction of a Cu(ll)-2,2' bicinchoninate chelate.
Our experience with this method has not been satisfactory.
On one occasion the aca reported an impossible serum uric acid value of 37.5 mg/dl in a hospitalized patient. When the same specimen was retested with a manual uricase method, the serum uric acid was found to be 9.0 mg/dl. Because of repeated evidence of false elevations of uric acid when we used the aca copper-chelate method, Du Pont placed a 293-nm interference filter in our instrument; which made it possible for us to measure uric acid by a new kinetic uricase assay. In this paper we report comparative data for four methods: the old Du Pont copper-chelate method (1), the Technicon "SMA 12/60" phosphotungstate method (2), a manual uricase end-point method (3), and the new uric ase kinetic method for use on the aca (4). In addition, each serum was measured in duplicate by each of the methods, to obtain a measure of precision. The coefficient of variation for the aca kinetic uricase method was 2.40%; that of the manual uncase method was 7.57%.
Materials and Methods

aca Kinetic Uricase vs. SMA 12/60
Aliquots of sera from 50 patients were measured both by the aca kinetic uricasemethod and by the SMA 12/60 phosphotungstate method. The results are shown in Figure 3 . The mean value forthe kinetic uricasemethod was 7.84 mg/dl (these were the In addition, each of the samples was measured in duplicate, to measure the precision. The CV for the SMA 12/60 method was 2.81% vs. 2.40% for the kinetic uricase method.
Interferences Table 1 lists the chemical substances found to interfere with the aca copper-chelate method and with the SMA 12/60 phosphotungstate method. The copper-chelate method is especially affected by known reducing substances such as ascorbic acid, glutathione, and resorcinol, as-well as by certain antibiotics and by DL-dopa. Results for the SMA 12/60 method are not affected by commonly used antibiotics, but are affected by amino acids such as cystine, tryptophan, and tyrosine.
Discussion
The Du Pont aca kinetic uricase method had the highest precision and the least interference by any substance tested. In addition, the aca kinetic uricase method gave results that were nearly identical to those obtained by a manual end-point uricase method. The manual unicase method, however, was less precise than the aca kinetic uricase method.
Our results demonstrate a significant and serious interference with the aca copper-chelate method by nonurate reducing substances. In addition to such commonly known interferences as glutathione and ascorbic acid (5-8), we found that high doses of frequently used antibiotics also interfered. In fact, patients with the highest false elevations were patients who were being treated with massive doses of antibiotics. Artif actual increases in apparent uric acid have been reported in patients receiving high doses of Ldopa (3 to 5 g/day) (9, 10). In our study an aqueous standard of 10 mg/dl of DL-dopa gave a false uric acid reading of 31.0 mg/dl by the aca copper-chelate method, and a false reading of 2.3 mg/dl by the SMA 12/60 phosphotungstate method. The unicase methods were unaffected.
Therefore, apparently supranormal concentrations of uric acid in the serum of patients who are receiving L-dopa cannot be interpreted unless a unicase assay is used. The phosphotungstate method was affected slightly by known reducing substances and by the amino acids tested. This helps to explain why the SMA 12/60 results were slightly but significantly higher than the results by the kinetic unicase method.
Finally, we tested the effect of chemical substances known to be present in excessive concentrations in the sera of uremic patients (11), but observed no effect.
